Association for accessible medicines

Biosimilar medicines

Biosimilar medicines contain the same active substance and have the same therapeutic effect as branded medicines. Their price is at least 35,8% to minimum 43,54% lower than the original price of the branded medicine. Biosimilars are essential to making expensive biologic treatments available as widely as possible.

Generic medicines

Generic medicines contain the same active substance and have the same therapeutic effect as branded medicines. Their price is at least between 54% and 65% lower than the original price of the branded medicine. Generic medicines allow more patients to be better treated.

Off-patent brands

Off-patent brand medicines are originator medicines whose patent has expired. To be considered cheap, their price must have decreased to a level generally comparable to that of most generic or biosimilar medicines. Cheap branded medicines help to keep healthcare accessible.

Self-care products

Self-care products are products that are freely available at pharmacies, such as self-care medicines, self-care medical devices and food supplements. Patients can use them upon their own initiative, to preserve their health. Their ‘good use’ substantially reduces the social costs of being ill.

News

With the support of the Belgian and Luxembourg Competent Authorities, in 2018 the pharmaceutical industry launched the 'e-PIL' pilot project in Belgian and Luxembourg hospitals. The project is the result of a derogation obtained from the European Commission. 

Replay of the Generic Medicines Day webinar (in Dutch and French)

Biosimilar medicines day
 

Facts & Figures

Factsandfigures

medaxes_generic_medicines_in_belgium_facts_figures_cover

/sites/default/files/styles/banner/public/2018-10/caleb-jones-135058.jpg?h=28fdc21a&itok=wU_tyZE5

Our members